Additionally, the APOE4 variant—the strongest genetic risk factor for AD except for mutations in APP and PS1/2—could affect the endocytosis process and increase Aβ accumulation at the blood–brain barrier (BBB) [24]. This evidence concerns the gene APOE and Alzheimer disease.